Mu-selective, but not non-selective, opioid receptor antagonism reduces L-DOPA induced dyskinesia in the MPTP macaque model of Parkinson's disease

被引:0
|
作者
Fox, S. H.
Koprich, J. B.
Johnston, T. H.
Goodman, A.
Le Bourdonnec, B.
Dolle, R. E.
DeHaven, R. N.
DeHaven, D. L.
Little, P. J.
Brotchie, J. M.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S412 / S412
页数:1
相关论文
共 50 条
  • [1] Mu opioid receptor agonism, not antagonism, for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Bezard, E.
    Li, Q.
    Pioli, E.
    Crossman, A.
    MOVEMENT DISORDERS, 2019, 34 : S134 - S134
  • [2] L-DOPA pharmacokinetics in the MPTP-lesioned macaque model of Parkinson's disease
    Huot, Philippe
    Johnston, Tom H.
    Koprich, James B.
    Fox, Susan H.
    Brotchie, Jonathan M.
    NEUROPHARMACOLOGY, 2012, 63 (05) : 829 - 836
  • [3] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [4] The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease
    Koprich, James B.
    Fox, Susan H.
    Johnston, Tom H.
    Goodman, Allan
    Le Bourdonnec, Bertrand
    Dolle, Roland E.
    DeHaven, Robert N.
    DeHaven-Hudkins, Diane L.
    Little, Patrick J.
    Brotchie, Jonathan M.
    MOVEMENT DISORDERS, 2011, 26 (07) : 1225 - 1233
  • [5] FP0011 extends the duration of the anti-parkinsonian actions of L-DOPA and reduces L-DOPA-induced dyskinesia in the MPTP-lesioned macaque model of Parkinson's disease
    Brotchie, J. M.
    Johnston, T. H.
    Fox, S. H.
    Zerr, P.
    Tiberghien, F.
    Bossi, L.
    MOVEMENT DISORDERS, 2007, 22 : S95 - S95
  • [6] Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
    Mitchell J. Bartlett
    Lisa Y. So
    Lajos Szabò
    David P. Skinner
    Kate L. Parent
    Michael L. Heien
    Todd W. Vanderah
    Robin Polt
    Scott J. Sherman
    Torsten Falk
    BMC Research Notes, 13
  • [7] Highly-selective μ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
    Bartlett, Mitchell J.
    So, Lisa Y.
    Szabo, Lajos
    Skinner, David P.
    Parent, Kate L.
    Heien, Michael L.
    Vanderah, Todd W.
    Polt, Robin
    Sherman, Scott J.
    Falk, Torsten
    BMC RESEARCH NOTES, 2020, 13 (01)
  • [8] μ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease
    Bezard, Erwan
    Li, Qin
    Hulme, Heather
    Fridjonsdottir, Elva
    Nilsson, Anna
    Pioli, Elsa
    Andren, Per E.
    Crossman, Alan R.
    JOURNAL OF NEUROSCIENCE, 2020, 40 (35): : 6812 - 6819
  • [9] The Selective α1 Adrenoceptor Antagonist HEAT Reduces L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease
    Buck, Kerstin
    Ferger, Boris
    SYNAPSE, 2010, 64 (02) : 117 - 126
  • [10] Molecular mechanism of L-Dopa induced dyskinesia in Parkinson's disease
    Subhani, F. U. -H.
    Subhani, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S119